Is lecanemab the Alzheimer’s drug that will finally make a difference?
(By Jon Hamilton for NPR) A drug that offers a small benefit to Alzheimer’s patients is making a big splash
Read More
Alzheimer’s/Dementia
Lecanemab approval being pursued for Alzheimer’s Treatment
Japan-based pharmaceutical company Eisai Co., Ltd. recently anno0unced plans to seek full approval for its Alzheimer’s treatment drug lecanemab, a
Read MoreStudy: Alzheimer’s drug shows modest success slowing declines in memory, thinking
(By Jon Hamilton for NPR) An experimental drug that removes a substance called amyloid from the brain appears to slow
Read MoreDementia rates fell 30% over 16 years — working and education may deserve credit
(By Mariah Taylor for Becker’s Hospital Review) Researchers from RAND Corporation, a nonprofit think tank, found dementia rates dropped by
Read MoreDepression And Alzheimer’s Treatments At A Crossroads
(By Jon Hamilton and Aaron Scott for NPR) Researchers are launching a make-or-break study to test the conventional wisdom about
Read MoreSupreme Court to Hear Nursing Home Case That Could Affect Millions
(By Farah Yousry, Side Effects Public Media for Kaiser Health News) When Susie Talevski sued the agency that managed her
Read More‘Front of the line’: For Alzheimer’s patients in successful trial, a feeling of gratitude
(By Andrew Joseph for Stat News dated October 20, 2022) When the news came out last month that an experimental
Read More‘Front of the line’: For Alzheimer’s patients in successful trial, a feeling of gratitude
(By Andrew Joseph for STAT) When the news came out last month that an experimental Alzheimer’s therapy succeeded in a
Read MoreFDA approves ALS drug from Amylyx, giving patients a much-needed treatment option
(By Damian Garde for STAT) The Food and Drug Administration approved a new medicine for ALS from Amylyx Pharmaceuticals on
Read MoreAn Alzheimer’s therapy scores winning results, but what could it mean for patients?
(By Andrew Joseph for STAT) The news Tuesday night that a clinical trial of an experimental Alzheimer’s therapy had succeeded
Read More